The National Institute for Health and Care Excellence (NICE) (2018) Attention deficit hyperactivity disorder: diagnosis and management., no. p. kleine verwachte eindlengte, 2018, [Online]. Available: https://www.nice.org.uk/guidance/ng87/resources/attention-deficit-hyperactivity-disorder-diagnosis-and-management-pdf-1837699732933

Wolraich ML, Hagan JF, Allan C, Chan E (2019) Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-De fi cit / Hyperactivity Disorder in Children and Adolescents. 144(4)

Cortese S et al (2018) Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis. Lancet Psychiatry 5(9):727–738. https://doi.org/10.1016/S2215-0366(18)30269-4

Article  PubMed  PubMed Central  Google Scholar 

Coghill D (2010) The impact of medications on quality of life in attention-deficit hyperactivity disorder: a systematic review. CNS Drugs 24(10):843–866. https://doi.org/10.2165/11537450-000000000-00000

Article  CAS  PubMed  Google Scholar 

Roest AM, De Vries YA, Wienen AW, De Jonge P (2022) Editorial Perspective: are treatments for childhood mental disorders helpful in the long run? An overview of systematic reviews. https://doi.org/10.1111/jcpp.13677

Beau-Lejdstrom R, Douglas I, Evans SJW, Smeeth L (2016) Latest trends in ADHD drug prescribing patterns in children in the UK: prevalence, incidence and persistence. BMJ Open 6(6):e010508. https://doi.org/10.1136/bmjopen-2015-010508

Article  PubMed  PubMed Central  Google Scholar 

Matthijssen A-FM et al Continued Benefits of Methylphenidate in ADHD After 2 Years in Clinical Practice: A Randomized Placebo-Controlled Discontinuation Study, American Journal of Psychiatry, p. appi.ajp.2019.1, 2019, https://doi.org/10.1176/appi.ajp.2019.18111296

Guy W (1976) ECDEU Assessment Manual for Psychopharmacology. Rockville, MD: US Department of Heath,Education, and Welfare Public Health Service Alcohol, Drug Abuse, and Mental Health Administration

Zhang S, Faries DE, Vowles M, Michelson D (2005) ADHD rating scale IV: psychometric properties from a multinational study as a clinician-administered instrument. Int J Methods Psychiatr Res. https://doi.org/10.1002/mpr.7

Article  PubMed  Google Scholar 

Association AP (2013) Diagnostic and statistical manual of mental disorder: DSM-5, 5th edn. ArlingtonL American Psychiatric Publishing, Inc., Washington, D.C.

Book  Google Scholar 

Van Widenfelt BM, Goedhart AW, Treffers PDA, Goodman R (2003) Dutch version of the strengths and difficulties Questionnaire (SDQ). Eur Child Adolesc Psychiatry. https://doi.org/10.1007/s00787-003-0341-3

Article  PubMed  Google Scholar 

Bussing R et al (2008) Parent and teacher SNAP-IV ratings of attention deficit hyperactivity disorder symptoms: psychometric properties and normative ratings from a school district sample. Assessment 15(3):317–328. https://doi.org/10.1177/1073191107313888

Article  PubMed  PubMed Central  Google Scholar 

Barkley RA, Mcmurray MB, Edelbrock CS, Robbins K (1990) Side effects of Metlyiphenidate in Children with attention deficit hyperactivity disorder. Pediatrics 86(2)

Conners CK, Sitarenios G, Parker JD, Epstein JN (1998) Revision and restandardization of the conners teacher rating scale (CTRS-R): Factor structure, reliability, and criterion validity. J Abnorm Child Psychol 26(4): 279–291

R Core Team: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria, 2021. [Online]. Available: https://www.r-project.org/

Cohen J (1988) Statistical Power Analysis for the behavioral sciences. Routledge

Kazda L et al (2021) Overdiagnosis of attention-deficit / hyperactivity disorder in children and adolescents a systematic scoping review. JAMA Nerwork Open 4(4):1–29. https://doi.org/10.1001/jamanetworkopen.2021.5335

Article  Google Scholar 

Matthijssen AFM et al (2020) Apr., Effects of Discontinuing Methylphenidate on Strengths and Difficulties, Quality of Life and Parenting Stress. J Child Adolesc Psychopharmacol 30(3):159–165. https://doi.org/10.1089/cap.2019.0147

Matthijssen AFM et al (2019) Continued benefits of methylphenidate in ADHD after 2 years in clinical practice: a randomized placebo-controlled discontinuation study. Am J Psychiatry 176(9):754–762. https://doi.org/10.1176/appi.ajp.2019.18111296

Article  PubMed  Google Scholar 

Tripp G, Schaughency EA, Clarke B (2006) Parent and teacher rating scales in the evaluation of attention-deficit hyperactivity disorder: contribution to diagnosis and differential diagnosis in clinically referred children. J Dev Behav Pediatr 27(3):209–218. https://doi.org/10.1097/00004703-200606000-00006

Article  PubMed  Google Scholar 

Fageera W et al (2017) Placebo response and its determinants in children with ADHD across multiple observers and settings: a randomized clinical trial. Int J Methods Psychiatr Res 27(1):1–10. https://doi.org/10.1002/mpr.1572

Article  Google Scholar 

Wang GJ et al (2013) Long-term stimulant treatment affects brain dopamine transporter level in patients with attention deficit hyperactive disorder. PLoS ONE 8(5):1–6. https://doi.org/10.1371/journal.pone.0063023

Article  CAS  Google Scholar 

Swanson JM et al (2018) Long-term outcomes in the multimodal treatment study of ADHD (the MTA): from beginning to end. In: Banachewski T, Coghill DR, Zuddas A (eds) in Oxford Textbook of attention deficit hyperactivity disorder. Oxford University Press, Oxford, pp 315–332

Google Scholar 

Wang D, Bahkai A (2006) Clinical Trials: A practical guide to design, analysis, and reporting, 1st Editio. Londen: Remedica

Matthijssen AFM et al (2022) Clinicians’ Adherence to Guidelines When Initiating Methylphenidate Treatment. J Child Adolesc Psychopharmacol 32(9):488–495. https://doi.org/10.1089/cap.2022.0060

Tandon M, Tillman R, Agrawal A, Luby J (2016) Trajectories of ADHD severity over 10 years from Childhood into Adulthood. 8(3):121–130. https://doi.org/10.1007/s12402-016-0191-8.Trajectories